<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03236441</url>
  </required_header>
  <id_info>
    <org_study_id>PRO17070546</org_study_id>
    <secondary_id>1R21DK113486-01A1</secondary_id>
    <nct_id>NCT03236441</nct_id>
  </id_info>
  <brief_title>Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury</brief_title>
  <acronym>BRICK</acronym>
  <official_title>Biochemical and Reno-protective Effects of Remote Ischemic Pre-conditioning on Contrast-induced Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oladipupo Olafiranye</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      This a prospective, double-blind, sham-controlled, randomized clinical trial to study the
      effects of remote ischemic preconditioning on contrast-induced acute kidney injury, vascular
      and renal biomarkers in patients with non-ST elevation myocardial infarction and unstable
      angina undergoing cardiac catheterization and percutaneous coronary intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The BRICK study is a prospective, double-blind, sham-controlled, randomized clinical trial in
      patients with non-ST elevation myocardial infarction and unstable angina undergoing cardiac
      catheterization and percutaneous coronary intervention who are at high risk for
      contrast-induced acute kidney injury. The study will investigate the effects of remote
      ischemic preconditioning before cardiac catheterization on rate of contrast induced acute
      kidney injury and novel biomarkers of renal injury/protection within 48hrs of cardiac
      catheterization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Contrast-induced acute kidney injury</measure>
    <time_frame>48 hours</time_frame>
    <description>Contrast-induced acute kidney injury is defined as a relative increase in serum creatinine of ≥ 0.3mg/dl at 48 hours post catheterization compared with initial creatinine before catheterization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers study</measure>
    <time_frame>0-48 hours</time_frame>
    <description>Novel vascular and renal biomarkers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Contrast-induced Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>RIPC Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 cycles of blood pressure cuff inflations to occlusive pressure of 200 mmHg for 5 minutes and deflation for 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-RIPC Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>3 cycles of blood pressure cuff inflations to non-occlusive pressure of 10 mmHg for 5 minutes and deflation for 5 minutes (Control)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>Remote ischemic preconditioning</description>
    <arm_group_label>RIPC Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham-RIPC</intervention_name>
    <description>Control</description>
    <arm_group_label>Sham-RIPC Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with non-ST elevation myocardial infarction or unstable angina

          -  Referral for cardiac catheterization and percutaneous coronary intervention

          -  Contrast-induced acute kidney injury risk score of ≥11

        Exclusion Criteria:

          -  Inability to give informed consent

          -  unstable blood pressure (systolic blood pressure &gt; 200 or &lt;90 mmHg)

          -  History of allergy to contrast media

          -  Peripheral vascular disease of upper limb

          -  Renal disease requiring dialysis

          -  Placement of arteriovenous fistula and arteriovenous graft
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oladipupo Olafiranye, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gretchen Bernardini, RN</last_name>
    <phone>412-647-2931</phone>
    <email>Gretchen.Bernardini@chp.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Linda Spearman</last_name>
    <phone>412-647-7976</phone>
    <email>spearmanln@upmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh School of Medicine</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gretchen Bernardini, RN</last_name>
      <phone>412-647-2931</phone>
      <email>Gretchen.Bernardini@chp.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2017</study_first_submitted>
  <study_first_submitted_qc>July 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2017</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Oladipupo Olafiranye</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine and Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>remote ischemic conditioning</keyword>
  <keyword>contrast-induced nephropathy</keyword>
  <keyword>cardiac catheterization</keyword>
  <keyword>coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

